Peptide glossary · FDA approval and drug labels
New drug application (NDA)
Checked against U.S. Food and Drug AdministrationPublished by PepVault
A new drug application (NDA) is the file a drug company sends the FDA to ask for approval to sell a new drug in the United States.
What it means
It must hold the drug’s data on chemistry, pharmacology, safety and effectiveness, and if the FDA approves it, the drug may be marketed in the US. Each one gets a number that Drugs@FDA lists beside the drug. This is the US meaning; a biologic goes through a biologics license application instead.
This page gives the term’s meaning in the United States; other countries’ rules differ.
Why it matters when you track peptides
The legal-status pages name a drug’s application where Drugs@FDA lists one, so an application number there marks an approved product.

Where you meet it
Checked against
U.S. Food and Drug Administration, “Drugs@FDA Glossary of Terms”